期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 24, 期 17, 页码 -出版社
MDPI
DOI: 10.3390/ijms241713611
关键词
nitric oxide; cancer; drug delivery; liposomes
Since the discovery of the cytotoxicity of high concentrations of nitric oxide (NO) to cancer cells, as well as its potential role in cancer treatment, numerous NO-donors have been developed to deliver NO to tumors. NO also enhances the effectiveness of anticancer drugs and reverses multi-drug resistance in tumor cells. This study explores various strategies for delivering NO to tumors using NO-donors, aiming to achieve targeted and efficient treatment with minimal toxicity.
Since the early observations that nitric oxide (& BULL;NO) at high concentrations is cytotoxic to cancer cells and that it may play an important role in the treatment of human cancers, a significant number of compounds (NO-donors) have been prepared to deliver & BULL;NO to tumors. & BULL;NO also sensitizes various clinically active anticancer drugs and has been shown to induce the reversal of multi-drug resistance in tumor cells expressing ATP-binding cassette-transporter proteins. For the successful treatment of cancers, & BULL;NO needs to be delivered precisely to tumors, and its adverse toxicity must be limited. Like other chemotherapeutics, the precise delivery of drugs has been a problem and various attempts have been made, such as the encapsulation of drugs in lipid polymers, to overcome this. This prospective study examines the use of various strategies for delivering & BULL;NO (using NO-donors) for the treatment of cancers. Finding and utilizing such a delivery system is an important step in delivering cytotoxic concentrations of & BULL;NO to tumors without adverse reactions, leading to a successful clinical outcome for patient management.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据